Beta Drugs Limited has submitted the Exchange a copy Srutinizers report of Extraordinary General Meeting held on February 04, 2026. Further, the company has informed the Exchange regarding voting results.
BETA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Beta Drugs Limited has filed the Scrutinizer's Report for its Extraordinary General Meeting (EGM) held on February 4, 2026 with the stock exchange. The company has also shared the voting results of the resolutions passed at the meeting. This is a standard regulatory disclosure required after any general meeting of shareholders. The actual voting outcomes, including the percentage of votes in favor and against each resolution, would be detailed in the attached report.
This is a routine procedural filing and does not by itself indicate any major event. Shareholders should review the voting results to understand which resolutions were passed and the level of shareholder support, as this can signal management's alignment with investor interests.